Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9319401 | European Urology | 2005 | 9 Pages |
Abstract
Long-term therapy with solifenacin resulted in a favourable tolerability profile, and was associated with improvements in efficacy parameters based on diary data recorded over a 12-month period. This balance of tolerability and efficacy with solifenacin was associated with excellent persistence with therapy. These results suggest that solifenacin may be useful for the long-term treatment of the chronic symptoms associated with OAB.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
F. Haab, L. Cardozo, C. Chapple, A.M. Ridder, for the Solifenacin Study Group for the Solifenacin Study Group,